Related Experiment Videos
Initial therapy of HIV infection
1Division of Infectious Diseases, The Johns Hopkins University School of Medicine, 1830 E. Monument Street, Rm. 443, Baltimore, MD 21287, USA. jgallant@jhmi.edu
Summary
Selecting the right initial antiretroviral therapy is crucial for long-term HIV viral load suppression. Careful consideration of patient factors and drug characteristics ensures treatment success and prevents drug resistance.
Area of Science:
- Infectious Diseases
- Virology
- Pharmacology
Background:
- Antiretroviral therapy (ART) has significantly improved outcomes for individuals with HIV.
- Emergence of drug-resistant HIV variants due to rapid mutation poses a threat to long-term treatment efficacy.
- The initial antiretroviral regimen is critical for achieving sustained viral load suppression.
Purpose of the Study:
- To highlight the importance of appropriate initial antiretroviral regimen selection.
- To outline key factors influencing the choice of first-line HIV therapy.
- To emphasize the impact of adherence on treatment outcomes.
Main Methods:
- Review of factors influencing first-line antiretroviral therapy selection.
- Consideration of drug pharmacokinetics, potency, tolerability, safety, and resistance.
- Assessment of adherence-related factors like regimen complexity and pill burden.
Main Results:
- Individualized treatment regimens are enabled by a growing number of drug classes.
- Baseline viral load, CD4 count, and drug properties are key selection criteria.
- Poor adherence, often linked to regimen complexity, is the primary cause of treatment failure.
Conclusions:
- Initial regimen selection necessitates a comprehensive evaluation of multiple factors.
- New antiretroviral drugs and classes with improved resistance and side effect profiles are in development.
- These advancements will expand therapeutic options for initial HIV treatment.